Hypebeans Unveils New Pop-Up Experience at THE SOUTHSIDE
Hypebeans, a communal destination serving quality coffee, has announced the opening of its latest pop-up location at THE SOUTHSIDE in Hong Kong. Running from July 14 to October 13, 2025, the pop-up offers Hypebeans' signature coffee experience and an updated menu.
To mark the launch, Hypebeans is reintroducing its summer favorite, Golden Black (HK$55 USD). This refreshing, citrusy cold coffee blends Americano and yuzu puree, creating a light, beer-head-like foam without milk, and is finished with invigorating lemon zest.
Hypebeans has also partnered with Midnight Bread Club, a local artisan sourdough bagel bakery, to offer an exclusive Corned Beef Cheese Sourdough Bagel (HK$52 USD), a savory nod to classic Hong Kong 'cha chaan teng' flavors. Midnight Bread Club's bestseller, the Double Cheese Ham Sourdough Bagel (HK$52), will also be available.
As a special welcome, Hypebeans offered a buy-one-get-one-free deal on all drinks from July 15 to July 17, 2025.
Check out the pop-up above. The Hypebeans SOUTHSIDE pop-up is open until October 13.
Hypebeans SOUTHSIDE Pop-upKiosk Unit G-F, THE SOUTHSIDEWong Chuk Hang, Hong KongOpening Hours: Monday – Friday: 8am – 7pmSaturday, Sunday and Public Holidays: 10am – 7pm*Opening hours may be subject to change.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Heavy-Duty Joysticks Lead Growth Due to Infrastructure and Automation Demands
The Industrial Switch Joystick Market, valued at USD 1.9 billion in 2024, is expected to reach USD 3.6 billion by 2032, growing at a CAGR of 8.18%. Driven by automation in construction and material handling, the market faces challenges from high costs and competition. Key players include Curtiss-Wright, Eaton, and Danfoss. Industrial Switch Joystick Market Dublin, July 15, 2025 (GLOBE NEWSWIRE) -- The "Industrial Switch Joystick Market Outlook 2025-2034: Market Share, and Growth Analysis By Application (Robotics, Heavy Machinery, Gaming), By Product Type, By End User, By Technology" report has been added to global Industrial Switch Joystick Market size is valued at USD 1.9 billion in 2024 and is projected to reach USD 3.6 billion by 2032, registering a compound annual growth rate (CAGR) of 8.18% over the forecast period. The industrial switch joystick market is witnessing steady growth driven by increasing automation in material handling, construction machinery, cranes, and marine control systems requiring reliable operator interface devices. Industrial switch joysticks enable rugged multi-directional control of hydraulic and electromechanical systems with robust mechanical designs suitable for harsh environments. Manufacturers are focusing on heavy-duty joysticks with ergonomic handles, modular switch configurations, and IP-rated sealing to withstand dust, vibration, and moisture. Growth is supported by rising construction and infrastructure projects, crane fleet expansions, and factory automation initiatives globally. Challenges include high installation costs, integration complexities with hydraulic and electronic control systems, and competition from electronic proportional joysticks in certain applications. Recent developments include Curtiss-Wright expanding heavy-duty joystick lines for off-highway equipment, Eaton launching industrial switch joysticks with improved sealing and tactile feedback, and Danfoss enhancing modular joystick controllers for mobile machinery. Key Insights Major trends include integration of modular switch configurations and ergonomic handles in industrial joysticks for construction equipment, cranes, and marine applications to improve operator comfort and system control. Drivers are rising construction and mining equipment demand, increasing infrastructure development globally, and automation of material handling equipment in warehouses and ports. Challenges include high capital and installation costs, complexities in integrating mechanical joysticks with modern electronic control systems, and competition from electronic proportional joysticks in advanced equipment. Companies focus on developing IP67-rated heavy-duty joysticks with customizable switch layouts and tactile feedback to enhance durability and usability in harsh environments. Recent developments include Curtiss-Wright expanding joystick offerings for cranes, Eaton introducing rugged industrial joysticks with improved sealing, and Danfoss enhancing modular switch joystick controllers for mobile machinery. What's Included in the Report Global Industrial Switch Joystick market size and growth projections, 2024- 2034 North America Industrial Switch Joystick market size and growth forecasts, 2024- 2034 (United States, Canada, Mexico) Europe market size and growth forecasts, 2024- 2034 (Germany, France, United Kingdom, Italy, Spain) Asia-Pacific Industrial Switch Joystick market size and growth forecasts, 2024- 2034 (China, India, Japan, South Korea, Australia) Middle East Africa Industrial Switch Joystick market size and growth estimate, 2024- 2034 (Middle East, Africa) South and Central America Industrial Switch Joystick market size and growth outlook, 2024- 2034 (Brazil, Argentina, Chile) Industrial Switch Joystick market size, share and CAGR of key products, applications, and other verticals, 2024- 2034 Short- and long-term Industrial Switch Joystick market trends, drivers, challenges, and opportunities Industrial Switch Joystick market insights, Porter's Five Forces analysis Profiles of 5 leading companies in the industry- overview, key strategies, financials, product portfolio and SWOT analysis Latest market news and developments Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2024 - 2032 Estimated Market Value (USD) in 2024 $1.9 Billion Forecasted Market Value (USD) by 2032 $3.6 Billion Compound Annual Growth Rate 8.1% Regions Covered Global Companies Featured APEM (IDEC Corporation) Grayhill, Inc. Otto Engineering, Inc. ALPS Alpine Co., Ltd. MEGATRON Elektronik GmbH & Co. KG Schneider Electric RAFI GmbH & Co. KG Honeywell International Inc. W. Gessmann GmbH Spohn + Burkhardt GmbH & Co. KG Herga Technology Ltd SureGrip Controls Inc. Electro-Mech Components, Inc. Elobau GmbH & Co. KG Marquardt GmbH For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Industrial Switch Joystick Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
an hour ago
- Yahoo
Canadian dollar to strengthen; analysts see 'systemic weakness' for USD through 2025
The Canadian dollar is expected to rise against its American counterpart through 2025, say analysts predicting investors will continue to shun the U.S. currency. ATB Capital Markets head of currencies Bill Kellett says the story remains one of U.S. dollar weakness, rather than loonie strength. He expects both currencies will underperform through the remainder of the year, with the American dollar falling harder than Canada's currency. 'USD weakness will likely outpace CAD weakness, setting up for a move lower in USD/CAD,' he wrote in a research report on Monday. 'We anticipate USD/CAD will drift moderately lower over the second half of 2025, edging down to the low 1.3000's.' U.S. President Donald Trump's chaotic trade agenda continues to stoke fears of rising inflation and softer growth among global investors. Uncertainty linked to Trump's unpredictable bursts of tariffs against major economies has raised questions about the stability of the U.S. dollar and its role as the global reserve currency. 'While dramatic capital rotation out of the U.S. is not a sustainable reality, the USD is showing signs of longer-term systemic weakness,' Kellett wrote. 'We expect the theme of USD weakness will continue through the balance of 2025, and this variable will be the main overarching factor impacting FX markets.' CIBC economists Avery Shenfeld and Katherine Judge agree. 'The Canadian dollar has remained on a strengthening trajectory recently, but that continues to be a reflection of the broad USD falling out of favour with investors, rather than a case of strong Canadian fundamentals,' they wrote in the bank's July foreign exchange report. 'Markets are pricing in a slightly more modest dose of easing from the Bank of Canada than we expect, and look to be too optimistic on Fed cuts,' they added. 'That leans towards pressure on the loonie in the near term, but progress on trade negotiations over the next few months could be an offset, leaving USDCAD relatively stable at 1.37 into the end of Q3.' Jeff Lagerquist is a senior reporter at Yahoo Finance Canada. Follow him on X @jefflagerquist. Download the Yahoo Finance app, available for Apple and Android.
Yahoo
an hour ago
- Yahoo
Intensified Competition is Likely to Drive Product Innovation and Refine Patient Management Strategies
India's diabetes market is projected to grow at 7.3% annually, reaching US$3.52 billion by 2025. Key trends include increased adoption of continuous glucose monitoring (CGM), digital health solutions, and advanced therapeutic devices. Regulatory updates and strategic partnerships are fostering growth. Indian Diabetes Devices and Therapeutics Market Dublin, July 08, 2025 (GLOBE NEWSWIRE) -- The "India Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update" report has been added to diabetes market in India is expected to grow by 7.3% on annual basis to reach US$3.52 billion in 2025. The diabetes market in the country has experienced robust growth during 2020-2024, achieving a CAGR of 7.7%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 6.1% during 2025-2029. By the end of 2029, the diabetes market is projected to expand from its 2024 value of USD 3.28 billion to approximately USD 4.77 billion. This report provides a detailed data-centric analysis of the diabetes industry in India, covering market opportunities and analysis across a range of diagnosis and monitoring devices, therapeutics, domains. With over 50+ KPIs at the country level, this report provides a comprehensive understanding of diabetes market dynamics, market size and forecast, and market share statistics. The Indian diabetes devices and therapeutics market is being reshaped by increased CGM adoption, enhanced digital health integration, advancements in therapeutic delivery systems, and evolving regulatory frameworks. These trends are expected to intensify over the next 2-4 years, leading to improved patient monitoring, more precise treatment adjustments, and overall market expansion. The Indian market features a blend of multinational corporations and domestic innovators in diabetes care. A multi-tiered healthcare system with diverse reimbursement pathways provides opportunities for established and emerging players. A dynamic mix of multinational leaders and emerging domestic players mark the Indian diabetes devices and therapeutics market. Recent strategic partnerships, mergers, and acquisitions are reshaping competitive dynamics, with a growing emphasis on digital integration and regulatory alignment. In the coming years, intensified competition and strategic consolidation are expected to drive innovation and enhance patient management across India. The competitive landscape is expected to evolve with further consolidation as multinational firms expand their digital health capabilities and local entrants secure strategic alliances. Industry reports suggest emerging segmentation between providers of conventional devices and those focusing on digital innovations. Intensified competition is likely to drive product innovation and refine patient management strategies. Over the next 2-4 years, strategic collaborations and market consolidation are expected to reinforce India's competitive positioning. Expand Adoption of Continuous Glucose Monitoring (CGM) Indian healthcare providers are incorporating continuous glucose monitoring systems into diabetes management programs across urban centers such as Delhi, Mumbai, and Bangalore. Pilot initiatives in multi-specialty hospitals are using CGM data to tailor treatment regimens. Recent revisions in reimbursement policies by state health schemes and updated clinical guidelines have supported broader CGM use. Local clinical studies emphasize the value of real-time glucose data to enhance glycemic control, aligning with global MedTech advancements. CGM adoption is expected to intensify as policy frameworks and clinical evidence mature. Enhanced monitoring will facilitate timely treatment modifications and better patient outcomes across India. Integrate Digital Health Solutions for Remote Monitoring Digital platforms for remote monitoring and telemedicine are being implemented in diabetes care settings in India. Regional health systems are piloting centralized dashboards to consolidate patient data and support remote consultations. Government initiatives to expand digital health infrastructure and increase investments in healthcare IT are key enablers. Broader shifts in healthcare delivery models, including insurer support for telemedicine, have accelerated this integration. Digital health solutions are anticipated to grow steadily, improving connectivity between patients and providers. Over the medium term, the trend is expected to intensify, resulting in more efficient clinical decision-making and diabetes management. Advance Therapeutic Delivery Systems Connected therapeutic devices, such as smart insulin pens and automated insulin pumps, are entering the Indian market. Clinical trials in leading hospitals evaluate these systems for their potential to improve dosing accuracy and adherence. Technological innovation and encouraging findings from local clinical evaluations support the development of these devices. Increased research and development investments and adjustments in reimbursement approaches further drive market entry. The adoption of connected therapeutic devices is expected to grow as clinical protocols and reimbursement models evolve. This trend may lead to more precise treatment regimens and overall improvements in diabetes management across India. Regulatory and Reimbursement Frameworks Indian regulatory authorities are updating approval processes and reimbursement models to better accommodate new diabetes devices and therapies. Recent guidelines from health agencies reflect efforts to streamline market access for innovative solutions. Broader healthcare reform initiatives and cost-containment strategies are prompting these regulatory adjustments. Recent publications highlight the need for clear reimbursement pathways to support conventional and digital diabetes care. A more defined regulatory framework is anticipated to boost market confidence and attract further investments in advanced diabetes technologies. These changes will likely intensify over the next few years, paving the way for broader market growth and improved patient access. Key Players and New Entrants Multinational manufacturers maintain a strong market presence through longstanding collaborations with major hospitals and clinics. These companies offer comprehensive portfolios that include both monitoring devices and therapeutic systems. Local startups and technology firms are entering the market with digital health solutions and connected therapeutic devices tailored to Indian needs. Recent market analyses indicate that these new entrants leverage regional pilot programs and strategic collaborations to gain traction. Review Recent Partnerships, Mergers, and Acquisitions Recent publications report partnerships between established firms and domestic innovators to enhance data connectivity and device interoperability. Mergers and acquisitions over the past 12 months suggest efforts to consolidate expertise and expand product offerings in the Indian market. These strategic activities contribute to a more integrated market landscape, fostering shared innovation and streamlined regulatory compliance. Consolidation trends align product development with the evolving needs of India's healthcare system. Diabetes Devices and Therapeutics Market Share by Category Diagnosis and Monitoring Devices Therapeutics Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices Blood Glucose Monitoring Devices Insulin Delivery Devices Diabetes Management and Mobile Applications Artificial Pancreas Devices Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices Self-Monitoring Blood Glucose Devices Continuous Blood Glucose Monitoring Devices Test Strips Lancets Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices Insulin Pumps Insulin Pens Insulin Syringes Diabetes Devices and Therapeutics Market Share by Therapeutics Oral Anti-Diabetic Drugs Insulin Non-Insulin Injectable Drugs Combination Drugs Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs Alpha-Glucosidase Inhibitors DPP-4 Inhibitors SGLT-2 Inhibitors Diabetes Devices and Therapeutics Market Share by Insulin Basal or Long-Acting Bolus or Fast-Acting Traditional Human Insulin Drugs Insulin Biosimilars Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs GLP-1 Receptor Agonists Amylin Analogue Diabetes Devices and Therapeutics Market Share by Combination Drugs Combination Insulin Oral Combination Diabetes Devices and Therapeutics Market Share by Route of Administration Subcutaneous Intravenous Others Diabetes Devices and Therapeutics Market Share by Type of Diabetes Type 1 Diabetes Type 2 Diabetes Diabetes Devices and Therapeutics Market Share by Distribution Channels Online Pharmacies Hospital Pharmacies Retail Pharmacies Diabetes Devices and Therapeutics Market Share by End User Hospitals Diabetes Clinics Homecare Key Attributes: Report Attribute Details No. of Pages 50 Forecast Period 2025 - 2029 Estimated Market Value (USD) in 2025 $3.76 Billion Forecasted Market Value (USD) by 2029 $4.77 Billion Compound Annual Growth Rate 6.1% Regions Covered India For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Indian Diabetes Devices and Therapeutics Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
